A series of 3,5-bis(arylidene)-4-piperidones (DAP compounds) are considered as synthetic analogs of curcumin for anticancer and anti-inflammatory properties. We performed structureactivity relationship studies by synthesizing a number of 3,5-bis(arylidene)-4-piperidones Nalkylated or acylated with nitroxides or their amine precursors as potent antioxidant moieties.
A series of 3,5-bis(arylidene)-4-piperidones (DAP compounds) are considered as synthetic analogs of curcumin for anticancer and anti-inflammatory properties. We performed structureactivity relationship studies by synthesizing a number of 3,5-bis(arylidene)-4-piperidones Nalkylated or acylated with nitroxides or their amine precursors as potent antioxidant moieties.
Both subtituents on arylidene rings and on piperidone nitrogen (five-or six-membered, 2-or 3-or 3,4-disubstituted, isoindoline nitroxides) were varied. The anticancer efficacy of the new DAP compounds was tested by measuring their cytotoxicity to cancer cell lines A2780 (human epithelial ovarian cancer cell line) and MCF-7 (human breast cancer cell line) and to H9c2, a noncancerous (healthy) cardiac cell line. The results showed that all DAP compounds induced a significant loss of cell viability in both the human cancer cell lines tested, however only pyrroline appended nitroxides (5c, 1 5e, 7, 9) showed limited toxicity toward noncancerous cell lines. Computer docking simulations support the biological activity tested.
These results suggest that antioxidant-conjugated DAPs will be useful as a safe and effective anticancer agent for cancer therapy.
Introduction
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)1,6-heptadien-3,5-dion), a natural component of the rhizome of curcuma longa, proved to be a powerful chemopreventive and anticancer agent [2] [3] [4] [5] having also anti-inflammatory 6 , antibacterial 7 and antioxidant properties. 8 However, the clinical use of curcumin has been limited due to its low anticancer activity and poor bioabsorption. In the last decade, a novel class of curcumin analogs, diarylidene piperidones (DAPs) has been developed by incorporating a piperidone link to the beta-diketone structure and fluoro-, methoxy-, hydroxyl-, chloro-, nitro-, dimethylamino substituents on the phenyl group. 9, 10 These curcumin anlogs exhibited multi-drug-resistance reverting 11, 12 and antimycobacterial 13 properties as well. The idea of evaluation of these compounds as antineoplastoic agents is based on the assumption that these compounds may be considered as
Mannich base of dienone and α,β-unsaturated ketones display anticancer properties via a mechanism of action comprising interactions with cellular thiols with little or no affinity for hydroxyl and amino group in nucleic acids. The 1,5-diaryl-3-oxo-1,4-pentadienyl groups considered to react at a primary binding site, however the bioactivity will be influenced by others structural units: such as acylating piperidone nitrogen increased cytotoxic potencies and increasing the electron-withdrawing properties of substituents on aromatic ring has advantageous effect on cytotoxicity. [14] [15] [16] [17] [18] However, dimethylenbridge between C2-C6 atoms in piperidone was accompanied by reduction of cytotoxic properties exerting a steric impedance to alignment at one or more binding sites as well as variation of hydrophobicity and hence membrane transportation properties. 16 In general the DAP compounds were more effective than curcumin in inhibiting the proliferation of a variety of cancer cell lines. EF24, with ortho-fluorinated phenyl group exhibited anticancer activity in vitro when tested using breast cancer, colon cancer and ovarian epithelial cancer. The study showed that the DAPs induce preferential toxicity in cancer cells while sparing noncancereous cells. The results suggest that the antioxidant (nitroxide)-conjugated DAPs will be useful as a safe and effective anticancer agents for cancer therapy.
Chemistry
A Claisen-Schmidt condensation between 4-piperidone hydrochloride and the appropriate aldehyde led to the formation of 3,5-bis(arylidene)-4-piperidones. Based on earlier X-ray crystallography data we propose compounds 1, 6, 8, 10 possess E stereochemistry. 10, 14, 15 The new N-acyl-3,5 bis(4-fluorobenzilydene)piperidin-4-ones were prepared by treatment of compound 1 with freshly prepared paramagnetic acyl chloride 2a 29 acetonitrile in the presence of K 2 CO 3 to give compounds 5a, 5b, 5c, 5d, , 5f, 5g, 5h. 
Results and discussion
The anticancer efficacy of the DAP compounds with various substituents on aromatic rings and on piperidone nitrogen was evaluated by measuring the cytotoxicity of the compounds to comtainig derivatives (1, 6, 8) exhibited greater cytotoxicity than 10 trimethoxy derivative (10) in accordance with previous findings. 14, 15 In all caseses the toxicity can be increased by modifying the 3,5-bis(arylidene)-4-piperidone compounds with nitroxides by acylation (3a, 3b) and by alkylation (5a-h, 7, 9, 11). In particular 3a, 3b demonstrated a substantial cytotoxic effect against A2780 and MCF-7 cells. Comparable cytotoxic efficacies were observed with 5c, 5e, 5f and 9 derivatives. The results further indicated that the DAPs were more cytotoxic to ovarian (A2780) cancer cell when compared to breast cancer cell.
Compounds containing 2-substituted pyrrolidine nitroxide (5a, 5b), 3,4-disubstituted nitroxide (5d), isoindoline-type nitroxides (5g, 5h) exhibited limited toxicity toward breast cancer cell lines.
We also compared the cytotoxicity of DAPs to a noncancerous (healthy) cardiac cell line, namely H9c2, an undifferentiated neonatal rat cardiomyoblast. Most of the compounds induced a significant loss of cell viability, although to different extents (Table 1- 3), the pyrroline-appended DAPs, 5c, 5e and 7 were significantly less toxic to the healthy cell.
Particularly, the results of 5c seem to suggest a strikingly differential effect on cancer versus noncancerous cells. The compound 6, which was toxic to breast cancer cell, was toxic to healthy cells to the same extent. In addition, this differential effect could stem from the Nhydroxypyrroline function. Overall the viability results seem to implicate the diarylidenylpiperidone group in inducing cytotoxicity and N-hydroxypyrroline group in protecting noncancerous cells.
We recently reported the anticancer efficacy of four DAPs, namely 1 and 8 without NOH function and 5c and 9 with NOH function against a number of cancerous (breast, colon, head and neck, liver, lung, ovarian, and prostate cancer) and noncancerous (smooth muscle, aortic 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 endothelial, and ovarian surface epithelial cells) human cell lines. 22 We observed that all four compounds induced significant loss of cell viability in cancer cells, while 5c and 9 showed significantly less cytotoxicity in noncancerous (healthy) cells. Electron paramagnetic resonance (EPR) measurements showed a metabolic conversion of the N-hydroxylamine function to nitroxide with significantly higher levels of the metabolite and superoxide radicalscavenging (antioxidant) activity in noncancerous cells when compared to cancer cells. phosphorylation. There was a significant reduction in STAT3 downstream target protein levels including Bcl-xL, Bcl-2, survivin, and vascular endothelial growth factor (VEGF),
suggesting that 5c exposure disrupted the JAK/STAT3-signaling pathway. In addition, compound 5c significantly inhibited the growth of the ovarian xenografted tumors in a dosage-dependent manner without any apparent toxicity. Western-blot analysis of the 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 xenograft tumor tissues showed that compound 5c inhibited pSTAT3 (Tyr705 and Ser727) and JAK1 and increased apoptotic markers cleaved caspase-3 and PARP. Overall, compound 5c exhibited significant cytotoxicity towards ovarian cancer cells by inhibition of the JAK/STAT3-signaling pathway. 1 
Molecular docking
We performed theoretical modeling calculations using AutoDock ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Experimental Section
Melting points were determined with a Boetius micro melting point apparatus and are General procedure for N-alkylation of 3,5-Bis(arylidene)piperidin-4-one (5a, 5b, 5c, 5d, 5f, 5g, 5h, 7, 9, 11):
A mixture of 1 or 6 or 8 or 10 HCl salt (5.0 mmol), K 2 CO 3 (1.38g, 10.0 mmol) in acetonitrile (20 mL) was stirred at rt. for 30 min., then alkyl bromide 4a-h (5.0 mmol) was added dissolved in acetonitrile (5 mL) and the mixture was stirred and refluxed till the consumption of the starting materials (~3 h). After cooling the inorganic salts were filtered off on sintered glass filter, washed with CHCl 3 (10 mL), the filtrate was evaporated and the residue was partitioned between CHCl 3 (20 mL) and water (10 mL). The organic phase was separated, the aqueus phase was washed with CHCl 3 (20 mL), the combined organic phase was dried 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
3,5-Bis(4-fluorobenzylidene)-1-[5-(2-oxyl-1,1,3,3-tetramethyl-1,3-dihydro-2H-isoindol)methyl]piperidin-4-one

3,5-Bis[4-(trifluoromethyl)benzylidene]piperidin-4-one (8):
A solution of 4-(trifluoromethyl)benzaldehyde ( determined from a set of preliminary experiments. All experiments were done using 8
replicates and repeated at least three times. Cell viability was expressed as a percent MTT viability of untreated cells.
In Silico Docking Simulations
Previously published work by our group 1, 22 has demonstrated that these compounds act upon the signal transducer and activator of transcription 3 (STAT3) pathway. This phenomenon was investigated in more detail through in silico molecular docking simulations using the freely-available program AutoDock (version 4.2). 38, 39 The target macromolecule used in these studies was a non-transformed murine STAT3 dimer downloaded from the RCSB Protein Data Bank (PDB ID: 3CWG). 40 Energy-minimized 3D molecular topographies of the DAP compounds were obtained using the Dundee PRODRG2 server. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 * The similarity of docked structures is measured by computing the rootmean-square deviation (rmsd) between the coordinates of the atoms and creating a clustering of the conformations based on these rmsd values. In this run, multiple binding conformation clusters were found, some with equivalent binding energies. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A series of 3,5-bis(arylidene)-4-piperidones (DAP) were synthesized and N-alkylated or acylated with nitroxides or their precursors (amine and hydroxylamine). It was found that DAP part have cytotoxic (anti-cancer) activity, while the NOH moiety functioned as a tissuespecific modulator (anti-oxidant) of cytotoxicity. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
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